Apreo Health Raises $130M Series B to Advance Airway Scaffold Trial and Early Commercialization
Apreo Health, a clinical-stage medical device company focused on a novel treatment for severe emphysema, today announced the successful closing of an oversubscribed $130 million Series B financing round. The round was co-led by new investors Bain Capital Life Sciences and Norwest, with additional participation from new investors F-Prime and
